It was a pleasure to speak with Lloyd Clark (Palmetto Retina Center, West Columbia, SC, USA) about injection protocols demonstrating improvements in the long-term management of diabetic retinopathy and diabetic macular oedema, and his views on current treatment trends.
Questions
- What injection protocols have demonstrated improvements in the long-term management of diabetic retinopathy and diabetic macular oedema? (00:24)
- Could you tell us a little about the trends for switching from one therapy to the other? (02:42)
- What other trends in treatment strategies would you like to highlight? (04:33)
Speaker Disclosure: Lloyd Clark discloses the following: Consultant for Bayer, Genentech/Roche, Regeneron Pharmaceuticals; honoraria from Genentech/Roche, Regeneron Pharmaceuticals; grant support from Bayer, Genentech/Roche, Kodiak Pharmaceuticals, Regeneron Pharmaceuticals.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.
Filmed in coverage of Kiaweh Eye 2021.
